Novo Nordisk A/S vs Tractor Supply Co — how do they compare? Novo Nordisk A/S trades at $38.64 (market cap $165.31B), while Tractor Supply Co trades at $33.7 (market cap $17.44B). The key difference: Novo Nordisk A/S is far larger — about 9.5× Tractor Supply Co's market cap, and Novo Nordisk A/S pays the higher dividend (4.71%). Which is the better fit depends on your goals — on Pluang, investors hold Novo Nordisk A/S for 116 Days and Tractor Supply Co for 89 Days on average.
| NVO | TSCO | |
|---|---|---|
Market Cap | $165.31B | $17.44B |
Volume | 11,432,838 | 10,598,723 |
Sector | Health | Consumer Cyclical |
52-Week High | $63.98 | $56.37 |
52-Week Low | $35.29 | $29.14 |
Typical Hold Time | 116 Days | 89 Days |
Enterprise Value | $179.56B | $23.76B |
Dividend Yield | 4.71% | 2.87% |
Signals from Pluang's Aura AI — not financial advice
Novo Nordisk (NVO) trades at $38.18, down 0.21% with a bearish technical signal. The stock shows strong fundamentals with a P/E of 9.66, net margin of 35.35%, and consistent earnings beats. Recent news highlights pipeline developments including Wegovy pill data and a $4 billion licensing deal expansion. Cash flow remains positive at $10.81B despite increased capital expenditures.
The outlook remains positive with 59% analyst buy ratings and a $44.67 price target representing 17% upside. Key risks include FDA delays for hemophilia drug denecimig and intensifying competition from Eli Lilly. Revenue growth continues at 6.6% annually with improving profitability margins supporting valuation expansion potential.
Tractor Supply (TSCO) trades at $33.48, up 2.95% today, showing resilience after recent earnings misses. The stock maintains a bullish technical outlook with strong moving average signals, though RSI levels suggest potential overbought conditions. Fundamentally, the company demonstrates consistent revenue growth reaching $15.52B in 2025, with healthy profitability metrics including 36.46% gross margin and 39.51% ROE. Recent corporate developments include new distribution center openings and ongoing community investment initiatives.
The investment outlook remains cautiously optimistic with a $36.76 consensus price target representing 9.8% upside potential. Key opportunities include the company's 17-year dividend growth streak and strategic expansion, while risks center on consecutive earnings misses and institutional selling pressure. The balanced analyst coverage (48% buy, 50% hold) reflects uncertainty about near-term performance amid cyclical headwinds.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →Tractor Supply is the largest operator of retail farm and ranch stores in the United States. The company targets recreational farmers and ranchers and has little exposure to commercial and industrial farm operations. Currently, the company operates 2,016 of its namesake banners in 49 states and 178 Petsense stores. Stores are typically located in towns outside of urban areas and in rural communities. In fiscal 2021, revenue consisted primarily of livestock and pet (47%), hardware, tools, and truck (21%), and seasonal gift and toy (21%).
Read more on TSCO →